Pharmadrug Inc. (PHRX.CN)
- Previous Close
0.0350 - Open
0.0300 - Bid 0.0250 x --
- Ask 0.0300 x --
- Day's Range
0.0300 - 0.0300 - 52 Week Range
0.0250 - 0.0750 - Volume
20,642 - Avg. Volume
249,664 - Market Cap (intraday)
2.819M - Beta (5Y Monthly) 2.91
- PE Ratio (TTM)
1.00 - EPS (TTM)
0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to vertically integrated elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. Further, the company also holds interest in Sairiyo Therapeutics Inc. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug Inc. is based in Toronto, Canada.
www.pharmadrug.ca--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PHRX.CN
Performance Overview: PHRX.CN
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHRX.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHRX.CN
Valuation Measures
Market Cap
2.82M
Enterprise Value
4.28M
Trailing P/E
1.03
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
2.73
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-4.89%
Return on Equity (ttm)
16.47%
Revenue (ttm)
-2.53k
Net Income Avi to Common (ttm)
1.45M
Diluted EPS (ttm)
0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
188.42k
Total Debt/Equity (mrq)
19.45%
Levered Free Cash Flow (ttm)
442.03k
Company Insights: PHRX.CN
PHRX.CN does not have Company Insights